Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a pre-clinical model
Conclusions:
Our findings demonstrate that the IBC clinical phenotype is promoted by signaling from the microenvironment perhaps in addition to tumor cell drivers.
Source: Breast Cancer Research - Category: Cancer & Oncology Authors: Lara LacerdaBisrat DebebDaniel SmithRichard LarsonTravis SolleyWei XuSavitri KrishnamurthyYun GongLawrence LevyThomas BuchholzNaoto UenoAnn KloppWendy Woodward Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Dermatology | Inflammatory Breast Cancer | Skin | Stem Cell Therapy | Stem Cells | Study | Tarceva